The estimated 21 million people each year who get typhoid fever must now face another life- threatening reality: The emergence of antibiotic-resistant typhoid strains.

Leaders in Fight Against Typhoid Express Hope in Light of New Vaccines

BANGKOK, THAILAND — November 5, 2013— The Coalition against Typhoid (CaT), an initiative of the Sabin Vaccine Institute, will convene scientists, researchers and biotech experts this week at the Vaccines for Enteric Diseases (VED) Conference to discuss how a highly anticipated conjugate typhoid vaccine could expedite global efforts to help prevent this disease. For the first time, children as young as six months of age can be protected against typhoid with a vaccine. Both adults and children will receive high levels of long lasting protection.

Novartis and Biological E agree to deliver affordable vaccines for typhoid and paratyphoid A fevers to developing world

Novartis today announced that it has entered into a development and licensing agreement with Biological E Limited (BioE), a biopharmaceutical company based in India, for two vaccines to protect against typhoid and paratyphoid fevers. The agreement advances the Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions.

Continue reading. 

The lack of a robust, sensitive, and easy-to-use diagnostic test is one of the most serious barriers to the control and prevention of typhoid fever.
In a recent TED Talk, “Let's talk crap. Seriously.”, UK-based journalist Rose George discussed the significance of sanitation and the lack of access to toilets as a root for larger public health problems around the world.
Earlier this month, the Coalition against Typhoid (CaT), along with partners at the Bangladesh Pediatric Association, the International Vaccine Institute andthe International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), convened the 8th International Conference on Typhoid Fever and Other Invasive Salmonelloses in Dhaka, Bangladesh. Researchers and health professionals, as well as local, national and international policy makers were in attendance.

Vaccine Advocacy & Education

The Vaccine Advocacy and Education program at Sabin is dedicated to reducing the burden of preventable diseases by bringing together key stakeholders and leaders in government, private sector and civil society in order to foster cooperation, share information and best practices, and develop improved vaccine policy and access.

Pages

Subscribe to RSS - Typhoid